The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease

被引:6
作者
Edith Aguilar-Olivos, Nancy [1 ]
Oria-Hernandez, Jesus [2 ]
Ponciano-Rodriguez, Guadalupe [3 ]
Carlos Chavez-Tapia, Norberto [4 ]
Uribe, Misael [4 ]
Mendez-Sanchez, Nahum [1 ]
机构
[1] Medica Sur Clin & Fdn, Liver Res Unit, Mexico City 14050, DF, Mexico
[2] Minist Hlth, Natl Inst Pediat, Biochem & Genet Lab, Mexico City, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Fac Med, Dept Publ Hlth, Mexico City 04510, DF, Mexico
[4] Medica Sur Clin & Fdn, Obes & Digest Dis Unit, Mexico City 14050, DF, Mexico
关键词
Biological markers; disease progression; DNA methylation; histones; liver; microRNAs; one-carbon metabolism; NICOTINAMIDE-N-METHYLTRANSFERASE; ATP-CITRATE LYASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; SIRT1; STEATOHEPATITIS; METABOLISM; MICE; METHYLATION; MICRORNAS;
D O I
10.2174/1389557515666150709115702
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Non-alcoholic fatty liver disease encompasses a spectrum of pathologies ranging from simple steatosis to non-alcoholic steatohepatitis. Patients with non-alcoholic steatohepatitis have increased risk of cirrhosis, liver failure and hepatocellular carcinoma. About 25% of subjects with simple steatosis progress to steatohepatitis; nowadays, the detailed pathological factors influencing the progression of non-alcoholic fatty liver disease remains unclear. It is proposed that genetic and environmental factors interact to determine the disease phenotype. Epigenetics could explain some relationships between genes and external influences. The epigenetic changes that have been related to non-alcoholic fatty liver disease are DNA methylation, one-carbon metabolism, histone modifications and the presence of micro-RNA. DNA methylation and micro-RNAs have been investigated in human samples, whereas histone modifications have only been studied until now in animal and cellular models. The aim of this study is to review the most relevant information about epigenetic changes in non-alcoholic steatohepatitis.
引用
收藏
页码:1187 / 1194
页数:8
相关论文
共 50 条
  • [41] A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease
    Nobili, V.
    Bedogni, G.
    Alisi, A.
    Pietrobattista, A.
    Alterio, A.
    Tiribelli, C.
    Agostoni, C.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2009, 94 (10) : 801 - 805
  • [42] Role of Selenoprotein W in participating in the progression of non-alcoholic fatty liver disease
    Miao, Zhiruo
    Wang, Wei
    Miao, Zhiying
    Cao, Qiyuan
    Xu, Shiwen
    REDOX BIOLOGY, 2024, 71
  • [43] The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease
    Mai, Huanzhuo
    Yang, Xing
    Xie, Yulan
    Zhou, Jie
    Wang, Qing
    Wei, Yiru
    Yang, Yuecong
    Lu, Dongjia
    Ye, Li
    Cui, Ping
    Liang, Hao
    Huang, Jiegang
    FRONTIERS IN MICROBIOLOGY, 2024, 14
  • [44] Systems-level organization of non-alcoholic fatty liver disease progression network
    Shubham, K.
    Vinay, L.
    Vinod, P. K.
    MOLECULAR BIOSYSTEMS, 2017, 13 (09) : 1898 - 1911
  • [45] Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
    Zailaie, Samar A.
    Khoja, Basmah B.
    Siddiqui, Jumana J.
    Mawardi, Mohammad H.
    Heaphy, Emily
    Aljagthmi, Amjad
    Sergi, Consolato M.
    NON-CODING RNA, 2024, 10 (01)
  • [46] The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease
    Del Ben, Maria
    Polimeni, Licia
    Baratta, Francesco
    Pastori, Daniele
    Angelico, Francesco
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (01) : 88 - 95
  • [47] Current treatment of non-alcoholic fatty liver disease
    Ahmed, Mohamed H.
    Byrne, Christopher D.
    DIABETES OBESITY & METABOLISM, 2009, 11 (03) : 188 - 195
  • [48] Mineralocorticoid receptors in non-alcoholic fatty liver disease
    Schreier, Barbara
    Zipprich, Alexander
    Uhlenhaut, Henriette
    Gekle, Michael
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (13) : 3165 - 3177
  • [49] The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease
    Thayer, Timothy E.
    Cardenas, Christian L. Lino
    Martyn, Trejeeve
    Nicholson, Christopher J.
    Traeger, Lisa
    Wunderer, Florian
    Slocum, Charles
    Sigurslid, Haakon
    Shakartzi, Hannah R.
    O'Rourke, Caitlin
    Shelton, Georgia
    Buswell, Mary D.
    Barnes, Hanna
    Neitzel, Leif R.
    Ledsky, Clara D.
    Li, Jason Pingcheng
    Burke, Megan F.
    Farber-Eger, Eric
    Perrien, Daniel S.
    Kumar, Ravindra
    Corey, Kathleen E.
    Wells, Quinn S.
    Bloch, Kenneth D.
    Hong, Charles C.
    Bloch, Donald B.
    Malhotra, Rajeev
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [50] The expanding role of fish models in understanding non-alcoholic fatty liver disease
    Asaoka, Yoichi
    Terai, Shuji
    Sakaida, Isao
    Nishina, Hiroshi
    DISEASE MODELS & MECHANISMS, 2013, 6 (04) : 905 - 914